Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Adaptimmune Therapeutics PLC (ADAP)  
$0.90 0.13 (12.78%) as of 4:30 Thu 4/18


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 154,660,000
Market Cap: 138.95(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.429 - $1.75
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Adaptimmune Therapeutics is a biopharmaceutical company focused on developing T-cell therapies for solid tumors. Co.'s proprietary SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables it to identify cancer targets, find and genetically engineer T-cell receptors against those targets, and produce therapeutic candidates (SPEAR T-cells) for administration to patients. Co. has clinical trials on its ADP-A2M4, ADP-A2M4CD8, each targeting the MAGE-A4 antigen, and ADP-A2AFP SPEAR T-cells targeting the alpha fetoprotein (AFP) cancer antigen in solid tumor types including non-small cell lung cancer, head and neck cancer, ovarian, urothelial, melanoma, and hepatocellular.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 39,000
Total Buy Value $0 $0 $0 $11,326
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 0 165,799 218,930 354,372
Total Sell Value $0 $124,385 $172,782 $411,912
Total People Sold 0 4 5 6
Total Sell Transactions 0 16 19 41
End Date 2024-01-18 2023-10-17 2023-04-18 2022-04-18

   
Records found: 44
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Wood Gavin Chief Financial Officer   •       –      –    2022-05-20 4 B $0.29 $11,326 D/D 39,000 96,000 2.74 -34%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2022-01-18 4 S $3.19 $35,416 D/D (11,096) 12,312 52%     
   Bertrand William C Jr Chief Operating Officer   •       –      –    2022-01-18 4 S $3.19 $13,942 D/D (4,368) 7,336 52%     
   Lunger John Chief Patient Supply Officer   •       –      –    2022-01-18 4 S $3.19 $13,942 D/D (4,368) 7,336 52%     
   Norry Elliot Chief Medical Officer   •       –      –    2022-01-18 4 S $3.19 $6,770 D/D (2,121) 3,529 52%     
   Bertrand William C Jr Chief Operating Officer   •       –      –    2022-01-12 4 S $3.54 $7,967 D/D (2,248) 3,754 56%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2022-01-12 4 S $3.54 $10,795 D/D (3,046) 3,356 56%     
   Norry Elliot Chief Medical Officer   •       –      –    2022-01-12 4 S $3.54 $3,027 D/D (854) 1,383 56%     
   Lunger John Chief Patient Supply Officer   •       –      –    2022-01-12 4 S $3.54 $3,813 D/D (1,076) 1,749 56%     
   Bertrand William C Jr Chief Operating Officer   •       –      –    2022-01-11 4 S $3.56 $13,409 D/D (3,770) 6,343 54%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2022-01-11 4 S $3.56 $51,081 D/D (14,362) 15,978 54%     
   Norry Elliot Chief Medical Officer   •       –      –    2022-01-11 4 S $3.56 $13,409 D/D (3,770) 6,343 54%     
   Lunger John Chief Patient Supply Officer   •       –      –    2022-01-11 4 S $3.56 $13,409 D/D (3,770) 6,343 54%     
   Norry Elliot Chief Medical Officer   •       –      –    2022-01-04 4 S $4.06 $3,451 D/D (849) 1,388 63%     
   Lunger John Chief Patient Supply Officer   •       –      –    2022-01-04 4 S $4.06 $4,349 D/D (1,070) 1,755 63%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2022-01-04 4 S $4.06 $22,483 D/D (5,532) 6,172 63%     
   Bertrand William C Jr Chief Operating Officer   •       –      –    2022-01-04 4 S $4.06 $14,184 D/D (3,490) 5,873 63%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2021-09-01 4 S $5.20 $14,452 D/D (2,782) 3,070 32%     
   Lunger John Chief Patient Supply Officer   •       –      –    2021-08-02 4 S $3.58 $10,536 D/D (2,939) 4,873 -3%     
   Lunger John Chief Patient Supply Officer   •       –      –    2021-07-02 4 S $4.26 $8,133 D/D (1,907) 3,170 -28%     
   Bertrand William C Jr Chief Operating Officer   •       –      –    2021-07-02 4 S $4.26 $18,659 D/D (4,375) 7,329 -28%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2021-06-28 4 S $4.37 $12,210 D/D (2,794) 3,058 -24%     
   Alleva Lawrence M Director   –       •      –    2021-06-01 4 B $0.79 $9,954 I/I 12,600 12,600 2.1 7%     
   Tayton-Martin Helena Katrina Chief Business Officer   •       –      –    2021-03-03 4 OE $0.16 $280,245 D/D 1,785,000 1,800,000     -
   Norry Elliot Chief Medical Officer   •       –      –    2021-01-19 4 S $5.67 $11,968 D/D (2,111) 3,539 15%     
  44 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us